Search

You searched for "oncology"

817 results found
JAMA Network screengrab image.

Keep an eye on Viagra™

3 February 2023 | | URO - Andrology
Many of the side-effects and contra-indications of sildenafil and other phosphodiesterase 5 (PDE 5) inhibitors for erectile dysfunction have become well known to doctors and pharmacists over the years. This study from the United States collected case reports of adverse...

Clear cell urothelial carcinoma: a highly aggressive morphological variant in the bladder and upper urinary tract

2 November 2023 | | URO - Urologic Oncology
Clear cell urothelial carcinoma (CCUC) is a rare morphological variant of transitional cell carcinoma (TCC). It can occur anywhere along the urothelial tract and is characterised histologically by high grade carcinoma with an abundance of clear, glycogen-rich cytoplasm [1]. Alternative...

Planning and doing a fellowship: advice during the COVID-19 era

1 July 2022 | | URO - Covid-19
To paraphrase Shakespeare, to do, or not to do a fellowship, that is the question. That may be your question; whether or not to pursue a fellowship, even more so due to the uncertainty of the COVID-19 pandemic. There are...

A Core Trainee’s Guide to Preparing for a Career in Urology

1 March 2014 | | URO - Core Urology
National Selection pits the best of the UK’s core surgical trainees (sorry – that includes EEC countries as well) against each other in a process that determines who is allowed to proceed into higher surgical training. For the successful, it...

Challenges of upper tract urothelial carcinoma

1 July 2022 | | URO - Urologic Oncology
Upper tract uroepithelial carcinoma (UTUC) is a fairly common disease which traditionally had poorer outcomes compared to bladder cancer. This is due to various factors leading to delayed diagnosis and problems in risk stratification. Continuing efforts have focused on early...

Use of Clavien-Dindo classification in urology part 1 – pelvic surgery

1 March 2016 | | URO - Urologic Oncology
There is no widely accepted system to classify postoperative complications. It is necessary to compare the outcome and complications while validating a new surgical procedure or one of the surgical approaches of a particular condition. Several parameters have long been...

William Harvey – Not All Heart!

1 July 2019 | | URO - Technology, URO - Urologic Oncology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). I expect you will have heard of William Harvey (1578-1657) the 17th Century...

History of prostate biopsy – part 2

1 September 2018 | | URO - Basic Science Research, URO - Urologic Oncology, URO - Technology
For Part 1 of this topic is available here. The major limitations of the transrectal ultrasound (TRUS) guided prostate biopsy (PBx) protocols are the risk of profound sepsis and the risk of persistently significant false negative rates, related to the...

Andrology Update

Andrology Update 2022 A detailed, expert analysis of the latest developments in andrology, sub-Edited by Asif Muneer. Comprising a details analysis of four key topics, consisting of the following: To skip directly to features, click the links below: Introduction- by...

Use of MRI in the evaluation of prostate cancer: part 1

1 January 2015 | | URO - Urologic Oncology, URO - Uroradiology
Introduction Prostate cancer remains the most commonly diagnosed cancer in males and the second leading cause of cancer related deaths in UK men, after lung cancer [1]. The incidence of prostate cancer in the UK has shown a rapid increase...

Focal therapy trials

6 November 2020 | | URO - Urologic Oncology
Men with localised prostate cancer have traditionally required whole gland treatment involving radical prostatectomy or radical radiation treatment, independent of disease location and size. Increasing evidence supports the use of active treatment only in those men diagnosed with prostate cancer...

Simple spit test could finally turn the tide on prostate cancer

10 April 2025
Saliva test which analyses genetic variants in DNA is better than the PSA blood test at assessing prostate cancer risk for some men, and doesn’t require a visit to the GP. The test gave fewer false positive results and picked...